Topic: How To Invest

Wall Street Stock Forecaster Hotline – Friday, August 12, 2022

Article Excerpt

PFIZER INC., $50.11, New York symbol PFE, is your #1 Income Buy for 2022. The company is one of the world’s largest makers of prescription drugs. Its top-selling brands include Lyrica (epilepsy), Celebrex and Enbrel (arthritis), and Prevnar (pneumonia). Pfizer has increased its dividend rate each year since 2011. Starting with the March 2022 payment, the company raised your quarterly dividend by 2.6%. Investors now receive $0.40 a share instead of $0.39. The new annual rate of $1.60 yields a solid 3.2%. The company continues to use the higher revenue and profits from its COVID-19 vaccines and treatments to buy smaller drugmakers with promising products. Its latest purchase is Global Blood Therapeutics, Inc. (Nasdaq symbol GBT). That firm specializes in treatments for sickle cell disease, a disorder that hinders the flow of blood and can lead to strokes. GBT’s main product is Oxbryta, which generated sales of $195 million in 2021. It’s also working on other drugs that, combined with Oxbryta, could lift sales of…

You are trying to access subscriber-only content.

To read this article, you may subscribe or sign in.
If you are already a subscriber, log in here.

If you wish to become a subscriber, click here. Or you may enjoy access to all our publications when you become a Member of Pat McKeough's Inner Circle Pro.